Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-26-003862
Filing Date
2026-06-02
Accepted
2026-06-02 07:40:04
Documents
2
Period of Report
2026-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_060226.htm 6-K 5933
2 PRESS RELEASE exh_991.htm EX-99.1 7288
  Complete submission text file 0001171843-26-003862.txt   14455
Mailing Address 1 ADELAIDE STREET EAST, SUITE 801 TORONTO Ontario, Canada M5C 2V9
Business Address 1 ADELAIDE STREET EAST, SUITE 801 TORONTO Ontario, Canada M5C 2V9 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 261053641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)